All Stories

  1. Correction: Impact of Aspirin on Primary Prevention of Cardiovascular Events in Patients with Elevated Lipoprotein(a): A Systematic Review and Meta-analysis
  2. Aortic valve area determination by planimetry: comparison of two-dimensional and three-dimensional transesophageal echocardiography – a systematic review and meta-analysis
  3. Beta-blockers: vasodilator agents (nebivolol or carvedilol) may add further on patients with obstructive sleep apnea
  4. Impact of Aspirin on Primary Prevention of Cardiovascular Events in Patients with Elevated Lipoprotein(a): A Systematic Review and Meta-analysis
  5. Left ventricular hypertrophy reporting, analysis and trial design
  6. The Placebo Effect in Chronic Thromboembolic Pulmonary Hypertension Trials: A Systematic Review and Meta-Analysis
  7. Association of Aspirin Use in Primary Prevention and Cardiovascular Events: A Retrospective Analysis of the VITAL Cohort
  8. Risk of infective endocarditis in patients with mitral valve prolapse: Systematic review with meta-analysis
  9. In-hospital mortality of high-risk pulmonary embolism: a nationwide population-based cohort study in Portugal from 2010 to 2018
  10. Role of myocardial microRNAs in the long-term ventricular remodelling of patients with aortic stenosis
  11. A Reconciliação da Medicação nos Cuidados de Saúde em Portugal
  12. The SAFEST study: The crucial role of primary health care in the diagnosis and management of atrial fibrillation
  13. Editor's Choice – Systematic Review and Meta-Analysis of Contemporary Abdominal Aortic Aneurysm Growth Rates
  14. Incidence of muscle symptoms in placebo arm among statin-intolerant patients: a systematic review with meta-analysis
  15. Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemic
  16. How to predict prognosis in patients with acute pulmonary embolism? Recent advances
  17. Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF
  18. Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis
  19. Direct oral anticoagulants vs vitamin K antagonist on dementia risk in atrial fibrillation: systematic review with meta-analysis
  20. Anticoagulação Oral e Incidência de Acidente Vascular Cerebral Associado a Fibrilhação Auricular em Portugal Continental: Um Estudo de Modelação
  21. Clinical Outcomes of Anticoagulated Patients With Atrial Fibrillation After Falls or Head Injury: Insights From RE-LY
  22. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis
  23. Expert perspectives on strategic factors for the management and prevention of heart failure in Portugal
  24. Endometriosis and cardiovascular disease: A systematic review and meta-analysis
  25. Prescrição de Benzodiazepinas e outros Sedativos na Administração Regional de Saúde de Lisboa e Vale do Tejo de 2013 a 2020: Um Estudo Retrospetivo
  26. Glossopharyngeal neuralgia with cardioinhibitory syncope: Is a permanent pacemaker required?
  27. Atrial fibrillation risk on Parkinson’s disease – a systematic review and meta-analysis
  28. Myocardial infarction and viral triggers: what do we know by now?
  29. Aspirin in diabetic patients at primary prevention: insights of the VITAL cohort
  30. Family history of premature myocardial infarction and the effect of aspirin
  31. Fish intake and risk of cardiovascular events: an analysis of the VITAL cohort
  32. Screening strategies for atrial fibrillation in the elderly population: a systematic review and network meta-analysis
  33. Cardiovascular and Respiratory Safety of Sedation Strategies Used in Transesophageal Echocardiography: A Systematic Review Incorporating Network Meta-Analysis
  34. Management of arterial hypertension: Challenges and opportunities
  35. The Accuracy of Hestia and Simplified PESI to Predict the Prognosis in Pulmonary Embolism: Systematic Review with Meta-analysis
  36. Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis
  37. Systematic Review and Meta-analysis of Physician Modified Endografts for Treatment of Thoraco-Abdominal and Complex Abdominal Aortic Aneurysms
  38. The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis
  39. The association of xanthelasma palpebrum with cardiovascular events: systematic review with meta-analysis
  40. Systematic reviews and meta-analysis published in indexed Portuguese medical journals: time trends and critical appraisal
  41. High sensitivity troponins: From the acute setting to the general population
  42. Does autosomal dominant polycystic kidney disease increase the risk of aortic aneurysm or dissection: a point of view based on a systematic review and meta-analysis
  43. Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis
  44. Incidence of acute aortic dissections in patients with out of hospital cardiac arrest: A systematic review and meta-analysis of observational studies
  45. Anticoagulation therapy in patients with post-operative atrial fibrillation: Systematic review with meta-analysis
  46. A systematic review and meta-analysis of the incidence of acute aortic dissections in population-based studies
  47. Incidence and Prevalence of Thoracic Aortic Aneurysms: A Systematic Review and Meta-analysis of Population-Based Studies
  48. The high-risk bleeding category of different scores in patients with venous thromboembolism: Systematic review and meta-analysis
  49. Abstract 11500: General Evaluation of the Aorta by Computed Tomography in a Latin Population
  50. COVID-19 and myocardial infarction
  51. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
  52. Risk of SARS‐CoV‐2 Infection and COVID‐19 Severity Associated With Exposure to Nonsteroidal Anti‐Inflammatory Drugs: Systematic Review and Meta‐Analysis
  53. Anticoagulation after typical atrial flutter ablation: Systematic review and meta‐analysis
  54. Low-Dose Colchicine in Coronary Artery Disease ― Systematic Review and Meta-Analysis ―
  55. Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis
  56. The impact of influenza vaccination in patients with cardiovascular disease: An overview of systematic reviews
  57. The Impact of Different Types of Shift Work on Blood Pressure and Hypertension: A Systematic Review and Meta-Analysis
  58. Cardiovascular and cerebrovascular risk markers in Parkinson’s disease: Results from a case−control study
  59. Atherosclerosis: The cost of illness in Portugal
  60. Os custos da aterosclerose em Portugal
  61. Does Parkinson's Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control Study
  62. Cochrane Corner: Withdrawal of antihypertensive drugs in older people
  63. Cochrane Corner: Withdrawal of antihypertensive drugs in older people
  64. Doxycycline is not Effective in Reducing Abdominal Aortic Aneurysm Growth: A Mini Systematic Review and Meta-Analysis of Randomised Controlled Trials
  65. Antithrombotic Therapy Recommendations in the European Society of Cardiology Guidelines: How Robust Are the Randomized Controlled Trials Underpinning Them?
  66. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe
  67. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 infection severity
  68. Soluble CD40 ligand expression in stable atherosclerosis: A systematic review and meta-analysis
  69. The Risk of Mortality Associated With Opioid Use in Patients With Acute Heart Failure: Systematic Review and Meta-analysis
  70. Safety and tolerability of sacubitril-valsartan: a systematic review and meta-analysis
  71. Fluoroquinolones Are Associated With Increased Risk of Aortic Aneurysm or Dissection: Systematic Review and Meta-analysis
  72. The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary Intervention
  73. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
  74. The incidence of thrombotic events with idarucizumab and andexanet alfa: A systematic review and meta-analysis
  75. Opioids prescribing trend between 2013 and 2017 in the Lisbon and Tagus Valley region, Portugal
  76. Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K Antagonists: a Systematic Review and Meta-analysis
  77. Synchronous and Metachronous Thoracic Aortic Aneurysms in Patients With Abdominal Aortic Aneurysms: A Systematic Review and Meta‐Analysis
  78. Reminder: Cardiovascular Patients Also Benefit from Influenza Vaccine
  79. Safety of coffee consumption after myocardial infarction: A systematic review and meta-analysis
  80. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment
  81. Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis
  82. Effect of oxygen supply on mortality in acute ST-elevation myocardial infarction: systematic review and meta-analysis
  83. N‐Terminal Pro‐B‐Type Natriuretic Peptide Levels in Parkinson's Disease
  84. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials
  85. The burden of atherosclerosis in Portugal
  86. Multimodality imaging in the recurrence of left ventricular pseudoaneurysm after surgical correction
  87. The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis
  88. Alterações Eletrocardiográficas Induzidas pela Hipotermia
  89. Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis
  90. Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis
  91. Reply to the letter ‘We never speak about sudden unexpected death in Parkinson’s disease’
  92. Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis
  93. Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease
  94. Cardiovascular events reported in randomized controlled trials in restless legs syndrome
  95. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review
  96. Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease
  97. Reply to letter: Does Parkinson’s disease increase the risk of cardiovascular events? A systematic review and meta‐analysis
  98. Physical Activity, Exercise, and Physiotherapy in Parkinson's Disease: Defining the Concepts
  99. The association of Influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series.
  100. Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: Contemporaneous Portuguese cross-sectional data
  101. Recommendations and levels of evidence in the guidelines of the European Society of Cardiology: current scenario and time trends
  102. Cochrane Corner: Perioperative beta-blockers for preventing surgery-related mortality and morbidity
  103. Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta‐analysis
  104. Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies
  105. Corrigendum to “Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis” [Arch. Gerontol. Geriatr. 81 (March–April) (2019) 209–214]
  106. Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review
  107. Morphine in acute coronary syndrome: systematic review and meta-analysis
  108. Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis
  109. Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis
  110. The current and future burden of heart failure in Portugal
  111. Fatores de Risco para Mortalidade Hospitalar na Endocardite Infecciosa
  112. Non-vitamin K antagonist oral anticoagulants (NOACs) in cardioversions: The past, the present and the future
  113. Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol
  114. Non-vitamin K antagonist oral anticoagulants and infective endocarditis
  115. Factors influencing patient delay before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The Stent for life initiative in Portugal
  116. Thrombus aspiration in patients with ST-elevation myocardial infarction: results of a national registry of interventional cardiology
  117. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study
  118. Novel Antithrombotic Drugs and Intraocular Bleeding
  119. Influenza vaccination and prevention of cardiovascular disease mortality
  120. Adoção da estratégia invasiva precoce no enfarte agudo do miocárdio sem supra desnivelamento de ST: análise dos resultados do Registo Nacional de Síndromas Coronárias Agudas
  121. The value of Time in Therapeutic Range in the prediction of outcomes at a populational level in patients treated with vitamin K antagonists
  122. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis
  123. Caffeine does not increase the arrhythmic burden in patients with heart failure and left ventricular systolic dysfunction
  124. Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis
  125. A era dos novos anticoagulantes orais em Portugal
  126. Accuracy of diagnostic tests for Legionnaires' disease: a systematic review
  127. Bioengineered Temporomandibular Joint Disk Implants: Study Protocol for a Two-Phase Exploratory Randomized Preclinical Pilot Trial in 18 Black Merino Sheep (TEMPOJIMS)
  128. Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis
  129. Are there effective interventions to prevent hospital-acquired Legionnaires' disease or to reduce environmental reservoirs of Legionella in hospitals? A systematic review
  130. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis
  131. Safety of non-vitamin K antagonist oral anticoagulants - coronary risks
  132. Cochrane Corner: uso do balão intra‐aórtico em doentes com enfarte agudo do miocárdio complicado com choque cardiogénico
  133. Bridging Anticoagulation in Patients with Atrial Fibrillation
  134. Complicações de enfarte do miocárdio: ecocardiograma para diagnóstico diferencial de sopro cardíaco
  135. Custo‐efetividade dos novos anticoagulantes orais na fibrilhação auricular em Portugal
  136. Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?
  137. Cochrane Corner: colchicina na pericardite aguda e recorrente
  138. Glaucoma Surgery and Anticoagulant Therapy—Reply
  139. Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants
  140. Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants
  141. Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis
  142. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis
  143. Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis
  144. Left ventricular thrombus in repaired Tetralogy of Fallot
  145. Pericardial bleeding risk with non-vitamin K oral anticoagulants: A meta-analysis
  146. Takotsubo cardiomyopathy, beyond ventriculography and classical bidimensional echocardiography
  147. Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
  148. Risk of insomnia with non-vitamin K oral anticoagulants: systematic review and meta-analysis
  149. How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis
  150. Carga e custo da fibrilhação auricular em Portugal
  151. Cochrane Corner – administração de corticosteroides para miocardite de etiologia viral
  152. Antithrombotic treatment in chronic heart failure and sinus rhythm: Systematic review
  153. The burnout stage of an apical hypertrophic cardiomyopathy
  154. Thromboembolic risk in the initiation, switch and interruption/re-initiation of oral anticoagulants: Do newcomers improve outcomes? Insights from a meta-analysis of RCTs
  155. Cochrane Corner: Qual é o impacto clínico da administração de oxigénio em doentes com enfarte agudo do miocárdio? Avaliação de uma revisão sistemática Cochrane
  156. Controlled pericardiocentesis in patients with cardiac tamponade complicating aortic dissection: Experience of a centre without cardiothoracic surgery
  157. Prevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal: revisão sistemática e meta‐análise de estudos observacionais
  158. Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis
  159. Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis
  160. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis
  161. Impacto da frequência posológica na adesão terapêutica em doenças cardiovasculares crónicas: revisão sistemática e meta‐análise
  162. Net clinical benefit outcome should be standardized in trials evaluating antithrombotic drugs: The example of NOACs in atrial fibrillation
  163. Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta‐analysis
  164. Dyspnea and Reversibility Profile of P2Y12 Antagonists: Systematic Review of New Antiplatelet Drugs
  165. The risk of infection with new oral anticoagulants: A meta-analysis
  166. Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
  167. Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study
  168. Cochrane corner - Antiagregantes plaquetários na doença renal crónica. Avaliação da revisão sistemática
  169. Warfarin, acetylsalicylic acid and risk of incident atrial fibrillation in patients with heart failure and sinus rhythm: A meta-analysis
  170. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies
  171. Infliximab Reduces Hospitalizations and Surgery Interventions in Patients With Inflammatory Bowel Disease
  172. Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise
  173. Um caso de tromboembolismo pulmonar e dissecção aórtica: importância do ecocardiograma
  174. Branded Versus Generic Clopidogrel in Cardiovascular Diseases
  175. Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
  176. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
  177. Rate versus rhythm control in atrial fibrillation and clinical outcomes: Updated systematic review and meta-analysis of randomized controlled trials
  178. Rate vs rhythm control in patients with atrial fibrillation and heart failure: A systematic review and meta-analysis of randomised controlled trials
  179. Educational Strategies to Reduce Serum Phosphorus in Hyperphosphatemic Patients With Chronic Kidney Disease: Systematic Review With Meta-analysis
  180. Skin antiseptics in venous puncture-site disinfection for prevention of blood culture contamination: systematic review with meta-analysis
  181. Deep Purple Urine